COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,024 Articles (22,627 medRxiv, 8,397 bioRxiv)

Most recent first Previous |  Page 2631: Articles 26301-26310  | Next

Covid-19 Epidemiological Factor Analysis: Identifying Principal Factors with Machine Learning
Dolgikh, S.
10.1101/2020.06.01.20119560 — Posted: 2020-06-05
Emergency calls are early indicators of ICU bed requirement during the COVID-19 epidemic
The COVID-19 APHP-Universities-INRIA-INSERM Group, , Riou, B.
10.1101/2020.06.02.20117499 — Posted: 2020-06-05
Association of Bacille Calmette-Guerin (BCG), Adult Pneumococcal and Adult Seasonal Influenza Vaccines with Covid-19 Adjusted Mortality Rates in Level 4 European countries
Gallagher, J., Watson, C., Ledwidge, M.
10.1101/2020.06.03.20121624 — Posted: 2020-06-05 Discussion: Onsite
Host response-based screening to identify undiagnosed cases of COVID-19and expand testing capacity
Cheemarla, N. R., Brito, A. F., Fauver, J. R., Alpert, T., Vogels, C. B. F., Omer, S. B., Ko, A., Grubaugh, N. D., Landry, M. L., Foxman, E. F.
10.1101/2020.06.04.20109306 — Posted: 2020-06-05
Peripheral blood immune status at clinical onset correlates with severity of Coronavirus Disease 2019
Santoro, N., Cignetti, A., Tenace, V., Casonato, I. C., Cosseddu, D., Vizzini, M., De Rosa, G., Geuna, M.
10.1101/2020.06.03.20116533 — Posted: 2020-06-05
Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19
YU, D., SUN, S., LI, Y., XI, W., JIN, D., SUN, K., YU, R., YAO, X., SONG, Z., YANG, A., LUO, R., ZOU, B., LIU, Y.
10.1101/2020.05.30.20117598 — Posted: 2020-06-05
Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity
Perkmann, T., Perkmann-Nagele, N., Breyer, M.-K., Breyer-Kohansal, R., Burghuber, O. C., Hartl, S., Aletaha, D., Sieghart, D., Quehenberger, P., Marculescu, R., Mucher, P., Strassl, R., Wagner, O. F., Binder, C. J., Haslacher, H.
10.1101/2020.06.04.20117911 — Posted: 2020-06-05 Discussion: Onsite
Discrete SIRIR modelling using empirical infection data shows that SARS-CoV-2 infection provides short-term immunity
McMahon, A., Robb, N. C.
10.1101/2020.06.03.20120113 — Posted: 2020-06-05
Overview on COVID-19 outbreak indicators across Brazilian federative units
Guerra-Shinohara, E. M., Weber, S. S., Paniz, C., Gomes, G. W., Shinohara, E. J., Gandra, T. B. R., Pereira, I. C., Jarcem, K. G., Zanre, R. F. d. A., Barreto, A. G., De Carli, A. D.
10.1101/2020.06.02.20120220 — Posted: 2020-06-05
Decontamination of face masks and filtering facepiece respirators via ultraviolet germicidal irradiation, hydrogen peroxide vaporisation, and use of dry heat inactivates an infectious SARS-CoV-2 surrogate virus.
Ludwig-Begall, L. F., Wielick, C., Dams, L., Nauwynck, H., Demeuldre, P.-F., Napp, A., Laperre, J., Haubruge, E., Thiry, E.
10.1101/2020.06.02.20119834 — Posted: 2020-06-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).